Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
|
AMERICAN SCIENCE & ENGINEERING, INC. (ASEI)
|
Add to portfolio |
|
|
|
| Price: |
$30.10
| | Metrics |
| OS: |
7.14
|
M
| |
-2
|
% ROE
|
| Market cap: |
$215
|
M
| |
-4
|
% ROIC
|
|
Net cash:
|
$74.1
|
M
| |
$10.38
|
per share
|
|
EV:
|
$141
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($1.3)
|
M
| |
|
|
|
EBIT
|
($4.5)
|
M
| |
|
|
| EPS |
($0.37)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Mar-31-16 | Mar-31-15 | Mar-31-14 | Mar-31-13 | Dec-31-12 | Sep-30-12 | Mar-31-12 | Dec-31-11 |
| Revenues | 103.0 | 126.8 | 190.2 | 186.7 | 145.2 | 95.5 | 203.6 | 166.4 |
| Revenue growth | -18.7% | -33.4% | 1.9% | -8.3% | -12.7% | -12.8% | -26.9% | |
| Cost of goods sold | 56.8 | 69.5 | 113.6 | 107.3 | 40.0 | 26.5 | 110.4 | 45.5 |
| Gross profit | 46.2 | 57.3 | 76.7 | 79.4 | 105.2 | 69.0 | 93.1 | 120.9 |
| Gross margin | 44.9% | 45.2% | 40.3% | 42.5% | 72.4% | 72.2% | 45.7% | 72.7% |
| Selling, general and administrative | 29.8 | 32.7 | 31.8 | 29.5 | 21.2 | 12.9 | 35.6 | 26.7 |
| Research and development | 21.7 | 23.4 | 22.1 | 23.6 | 18.9 | 13.6 | 25.5 | 18.7 |
| EBIT | -5.3 | 1.2 | 22.8 | 26.3 | 25.1 | 16.0 | 31.9 | 30.0 |
| EBIT margin | -5.2% | 0.9% | 12.0% | 14.1% | 17.3% | 16.7% | 15.7% | 18.0% |
| Pre-tax income | -5.5 | 1.0 | 22.7 | 26.4 | 25.3 | 16.1 | 32.5 | 30.4 |
| Income taxes | -2.3 | 0.1 | 7.6 | 9.0 | 8.6 | 5.5 | 11.0 | 10.3 |
| Tax rate | 41.0% | 6.5% | 33.5% | 34.0% | 34.0% | 34.0% | 34.0% | 34.0% |
| Net income | -3.2 | 1.0 | 15.1 | 17.5 | 16.7 | 10.6 | 21.4 | 20.1 |
| Net margin | -3.2% | 0.8% | 7.9% | 9.3% | 11.5% | 11.1% | 10.5% | 12.1% |
| |
| Diluted EPS | ($0.45) | $0.13 | $1.92 | $2.07 | $1.95 | $1.22 | $2.34 | $2.18 |
| Shares outstanding (diluted) | 7.2 | 7.7 | 7.9 | 8.4 | 8.5 | 8.7 | 9.1 | 9.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|